BMRN vs PRM · P/E 40, rev $1.76B vs rev $338.9M
Biomarin Pharmaceutical Inc (BMRN) versus Perimeter Solutions SA (PRM) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Perimeter Solutions SA (PRM) is a specialty chemicals company listed on NYSE.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported PRM revenue for 2026-06-30 was $338.9M. Net income was -$108.7M. PRM currently screens at market cap $5.95B.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. PRM currently screens at market cap $5.95B.
Not investment advice. Open the BMRN and PRM stock pages for the full models.
Not investment advice.